Invention Grant
- Patent Title: Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same
-
Application No.: US15286708Application Date: 2016-10-06
-
Publication No.: US09765131B2Publication Date: 2017-09-19
- Inventor: Sung Youb Jung , Myung Hyun Jang , Ling Ai Shen , Young Kyung Park , Young Jin Park , Se Chang Kwon
- Applicant: Hanmi Science Co., Ltd.
- Applicant Address: KR Hwaseong-Si, Gyeonggi-Do
- Assignee: Hanmi Science Co., Ltd.
- Current Assignee: Hanmi Science Co., Ltd.
- Current Assignee Address: KR Hwaseong-Si, Gyeonggi-Do
- Agency: Baker & Hostetler LLP
- Priority: KR10-2011-0056472 20110610
- Main IPC: A61K38/26
- IPC: A61K38/26 ; C07K14/605 ; A61K45/06 ; A61K38/17 ; A61P3/04 ; C07K14/705 ; A61K38/22 ; C07K14/575 ; A61K38/00
Abstract:
The present invention relates to a novel peptide showing more excellent activities on a glucagon like peptide-1 receptor and a glucagon receptor than native oxyntomodulin, and a composition for the prevention or treatment of obesity comprising the peptide as an active ingredient. Unlike native oxyntomodulin, the novel peptide of the present invention reduces food intake, suppresses gastric emptying, and facilitates lipolysis with reduced side-effects, and also shows excellent receptor-activating effects. Thus, it can be widely used in the treatment of obesity with safety and efficacy.
Public/Granted literature
- US20170022261A1 Novel Oxyntomodulin Derivatives and Pharmaceutical Composition For Treating Obesity Comprising the Same Public/Granted day:2017-01-26
Information query
IPC分类:
